Keyphrases
Donor-acceptor
57%
D Study
45%
HIV Patients
45%
Confidence Interval
44%
Myocardial Infarction
35%
Adverse Events
33%
HIV-positive
32%
Hepatocellular Carcinoma
27%
Cardiovascular Risk
26%
Cirrhosis
23%
Anti-HIV Drugs
23%
Decompensated Cirrhosis
22%
Placebo
21%
Randomized Controlled Trial
21%
Combined Antiretroviral Therapy (cART)
20%
AIDS/HIV
19%
Cardiovascular Disease
19%
Sorafenib
18%
Randomized Clinical Trial
16%
Risk Factors
15%
Hazard Ratio
15%
Antiretroviral Therapy
15%
Odds Ratio
13%
Highly Active Antiretroviral Therapy (HAART)
13%
Clinical Trials
13%
Hepatitis C Virus
12%
Estimated Glomerular Filtration Rate
12%
Hemodialysis
12%
All-cause Mortality
12%
High Risk
12%
Liver Transplantation
12%
Meta-analysis
11%
Triflusal
11%
Online Hemodiafiltration
11%
Chronic Kidney Disease
11%
Direct-acting Antivirals
10%
Overall Survival
10%
Bariatric Surgery
10%
Spain
10%
CD4 Count
10%
Randomized Double-blind
10%
Dermatological Adverse Effects
9%
Hypertension
9%
Protease Inhibitors
9%
Incidence Rate
9%
Diabetes
9%
Hemodiafiltration
9%
Non-AIDS Events
9%
Stavudine
8%
People Living with HIV (PLHIV)
8%
Pharmacology, Toxicology and Pharmaceutical Science
HIV
100%
Adverse Event
53%
Cardiovascular Disease
33%
Liver Cirrhosis
32%
Heart Infarction
30%
Liver Cell Carcinoma
29%
Placebo
29%
Anti-Human Immunodeficiency Virus
27%
Cohort Study
23%
Clinical Trial
22%
Infection
19%
Cerebrovascular Accident
19%
Malignant Neoplasm
18%
Randomized Controlled Trial
18%
Sorafenib
16%
Hepatitis C Virus
14%
Disease
14%
Overall Survival
13%
Chronic Kidney Failure
13%
Decompensated Liver Cirrhosis
12%
Randomized Clinical Trial
12%
Triflusal
11%
Hemodialysis
11%
Neoplasm
10%
Proteinase Inhibitor
10%
Prevalence
10%
All Cause Mortality
10%
Syndrome
9%
Diabetes Mellitus
9%
Antivirus Agent
9%
Non Insulin Dependent Diabetes Mellitus
9%
Human Immunodeficiency Virus Infection
8%
Dexketoprofen
8%
Hepatitis C
8%
Normal Human
8%
Mortality Rate
8%
Bleeding
8%
Metastatic Colorectal Cancer
8%
Tolerability
7%
Dermatological Agent
7%
Recurrent Disease
7%
Simvastatin
7%
Abacavir
7%
Observational Study
7%
Cardiovascular Risk
6%
Creatinine
6%
Acetylsalicylic Acid
6%
Portal Hypertension
6%
Inflammation
6%
Combination Therapy
6%
Medicine and Dentistry
Human Immunodeficiency Virus
69%
Liver Cirrhosis
32%
Hepatocellular Carcinoma
32%
Adverse Event
27%
Cohort Analysis
23%
Apoplexy
20%
Antiretroviral Therapy
19%
Placebo
17%
Cardiovascular Disease
17%
Meta-Analysis
16%
Sorafenib
16%
Hepatitis C Virus
16%
Randomized Controlled Trial
14%
Clinical Trial
14%
Malignant Neoplasm
13%
Neoplasm
12%
Infection
12%
Chronic Kidney Disease
12%
Glomerular Filtration Rate
11%
Randomized Clinical Trial
11%
Highly Active Antiretroviral Therapy
10%
Antivirus Agent
10%
Brain Ischemia
10%
Liver Transplantation
10%
Overall Survival
10%
Anti-Human Immunodeficiency Virus
10%
Liver Cancer
10%
Bariatric Surgery
10%
Diseases
9%
Bleeding
9%
Dermatological Agent
9%
Cancer
9%
Hepatitis C
9%
Kidney Function
9%
Diabetes Mellitus
8%
Portal Hypertension
8%
Diabetes
8%
Body Mass Index
8%
Recurrent Disease
8%
Prospective Study
8%
Observational Study
7%
Transjugular Intrahepatic Portosystemic Shunt
7%
Patient-Data
7%
Creatinine
7%
Hazard Ratio
7%
Cardiovascular System
7%
Antiviral Therapy
6%
Cell Count
6%
Prevalence
6%
Maturity Onset Diabetes of the Young
6%
